Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (531-540 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2016
Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's diseaseAnna E Leeuwis, Marije R Benedictus, Joost P A Kuijer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2019
Comorbid amyloid-β pathology affects clinical and imaging features in VCDJolien F Leijenaar, Colin Groot, Carole H Sudre, et al.
European Journal of Human Genetics : EJHG|September 28, 2018
Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's diseaseNiccolò Tesi, Sven J van der Lee, Marc Hulsman, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
An Operational Definition of 'Abnormal Cognition' to Optimize the Prediction of Progression to Dementia: What Are Optimal Cut-Off Points for Univariate and Multivariate Normative Comparisons?Nathalie R de Vent, Joost A Agelink van Rentergem, Hilde M Huizenga, et al.
Brain : a Journal of Neurology|November 22, 2018
Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathyAnanya Chakraborty, Alwin Kamermans, Bert van Het Hof, et al.
Neuroradiology|April 14, 2020
Evaluating severity of white matter lesions from computed tomography images with convolutional neural networkJohanna Pitkänen, Juha Koikkalainen, Tuomas Nieminen, et al.
Alzheimer'S Research & Therapy|September 29, 2018
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's diseaseSusanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
Neurobiology of Aging|December 17, 2010
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performanceMichael Ewers, Cathal Walsh, John Q Trojanowski, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's diseaseNienke M E Scheltens, Casper T Briels, Maqsood Yaqub, et al.
British Journal of Clinical Pharmacology|December 29, 2021
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's diseaseAnne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar, et al.
Pageof 91

Showing results (531-540 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 4, 2016
Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's diseaseAnna E Leeuwis, Marije R Benedictus, Joost P A Kuijer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2019
Comorbid amyloid-β pathology affects clinical and imaging features in VCDJolien F Leijenaar, Colin Groot, Carole H Sudre, et al.
European Journal of Human Genetics : EJHG|September 28, 2018
Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's diseaseNiccolò Tesi, Sven J van der Lee, Marc Hulsman, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
An Operational Definition of 'Abnormal Cognition' to Optimize the Prediction of Progression to Dementia: What Are Optimal Cut-Off Points for Univariate and Multivariate Normative Comparisons?Nathalie R de Vent, Joost A Agelink van Rentergem, Hilde M Huizenga, et al.
Brain : a Journal of Neurology|November 22, 2018
Angiopoietin like-4 as a novel vascular mediator in capillary cerebral amyloid angiopathyAnanya Chakraborty, Alwin Kamermans, Bert van Het Hof, et al.
Neuroradiology|April 14, 2020
Evaluating severity of white matter lesions from computed tomography images with convolutional neural networkJohanna Pitkänen, Juha Koikkalainen, Tuomas Nieminen, et al.
Alzheimer'S Research & Therapy|September 29, 2018
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's diseaseSusanne Ostrowitzki, Robert A Lasser, Ernest Dorflinger, et al.
Neurobiology of Aging|December 17, 2010
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performanceMichael Ewers, Cathal Walsh, John Q Trojanowski, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 26, 2019
Exploring effects of Souvenaid on cerebral glucose metabolism in Alzheimer's diseaseNienke M E Scheltens, Casper T Briels, Maqsood Yaqub, et al.
British Journal of Clinical Pharmacology|December 29, 2021
Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's diseaseAnne Catrien Baakman, Carmen Gavan, Lotte van Doeselaar, et al.
Pageof 91